Terapötik Gen Teslimatı ve Parkinson Hastalığının Tedavisi İçin Uygulaması için Lipopolipleks.
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's Disease.
DOI: 10.3389/fnagi.2016.00068PMID: 27092073
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's Disease.
DOI: 10.3389/fnagi.2016.00068PMID: 27092073
Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety.
DOI: 10.1212/wnl.0000000000002510PMID: 27044646
Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease.
DOI: 10.1212/wnl.0000000000002511PMID: 27044647
Levodopa therapy for Parkinson disease: A look backward and forward.
DOI: 10.1212/wnl.0000000000002509PMID: 27044648
Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
DOI: 10.1016/j.neuropharm.2016.03.036PMID: 27055772
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
DOI: 10.1016/j.smim.2016.03.015PMID: 27049459
Erratum to: Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline.
DOI: 10.1007/s10072-016-2511-3PMID: 26897020
Novel Approaches to Optimization of Levodopa Therapy for Parkinson's Disease.
DOI: 10.1007/s11910-016-0635-8PMID: 26898686
Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
DOI: 10.1042/cs20150153PMID: 26957644
Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.
DOI: 10.2217/nmt-2016-0002PMID: 27033556
Corrigendum to "Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders".
DOI: 10.1038/mt.2016.58PMID: 27081723
Advances in levodopa therapy for Parkinson disease.
DOI: 10.1212/wnl.0000000000002513PMID: 27500293
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.